Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor

Clinical Trial

Offered by: Nemours Children's Health, Jacksonville
Location: Jacksonville, Fla.

Trial Name

SCUSF 0901 Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor

What is the trial about?

To compare the effects of Modafinil given to children with neurocognitive changes following treatment for brain cancer.

Who can participate?

Age ≥6 years and ≤17 years 10 months at the time of study entry.

What is involved?

Length of study is 10 weeks. Includes neurocognitive tests and physical exam.